New eye drop aims to tame ocular pain in early trial

NCT ID NCT07717918

Recruiting now Symptom relief Sponsor: Bausch & Lomb Incorporated Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests whether BL1332 eye drops can reduce eye pain caused by capsaicin (the spicy ingredient in chili peppers) in healthy adults aged 18 to 65. Participants receive either BL1332 or a placebo eye drop, and then rate their pain on a 0-to-10 scale. The goal is to see if BL1332 safely eases eye pain, which could lead to new treatments for conditions like dry eye or post-surgery discomfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BL1332 eye drops
What this could lead to: If successful, BL1332 could become a new option for treating eye pain, such as from injury or surgery.
What could go wrong: This is an early phase 1 trial with only 28 healthy people, so it may not work in real patients or have unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Site 101
RECRUITING

Newport Beach, California, 92663, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.